Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
32.5%
% of HRTS's 41 holdings also in GDOC
35.1%
% of GDOC's 39 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 9.7% | 9.7% |
|
UNITEDHEALTH GROUP INC | 6.0% | 5.2% | 5.2% |
 |
ASTRAZENECA PLC | 4.1% | 4.2% | 4.1% |
|
ABBOTT LABORATORIES | 3.8% | 5.2% | 3.8% |
 |
NOVO NORDISK A/S-B | 3.9% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to GDOC
|
BRIDGEBIO PHARMA, INC. | 4.2% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
GILEAD SCIENCES INC | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
 |
MEDTRONIC PLC | 3.0% |
|
NOVARTIS AG | 2.9% |
|
CRINETICS PHARMACEUTICALS INC | 2.6% |
|
BRISTOL-MYERS SQUIBB CO | 2.6% |
|
CYTOKINETICS INC | 2.3% |
HRTS Underweight Relative to GDOC
|
INTUITIVE SURGICAL INC | -5.8% |
|
BOSTON SCIENTIFIC CORP | -5.3% |
|
ABBVIE INC | -4.0% |
|
COOPER COS INC/THE | -3.8% |
|
BIOMARIN PHARMACEUTICAL INC | -3.3% |
 |
CSL LIMITED | -3.1% |
|
LONZA GROUP AG-REG | -2.9% |
|
INSULET CORP | -2.7% |
|
VEEVA SYSTEMS INC-CLASS A | -2.5% |
 |
HOYA CORP | -2.5% |